jemma ai

[jemma ai @jemma_ai]

@MEstherGallardo @Biomed_MDPI If you are interested in submitting an article/review, please feel free to contact me ([email protected]). 🤩🤩🤩

[M. Esther Gallardo @MEstherGallardo]

New SI about induced pluripotent stem cells is opened. Your contributions in this field are particularly welcome. @jemma_ai @Biomed_MDPI

[Biomedicines MDPI @Biomed_MDPI]

👉We feel excited to share the news that Biomedicines has received an #ImpactFactor of 4.7 from #JCR 2022.
Biomedicines ranks at
69/277 (#Q1) in #pharmacology & #Pharmacy
54/136 (Q2) in #medicine , #research & #experimental
92/285 (Q2) in Biochemistry & Molecular Biology

[jemma ai @jemma_ai]

New Achievement！ 😍😍😍

[Biomedicines MDPI @Biomed_MDPI]

👉We feel excited to share the news that Biomedicines has received an #ImpactFactor of 4.7 from #JCR 2022.
Biomedicines ranks at
69/277 (#Q1) in #pharmacology & #Pharmacy
54/136 (Q2) in #medicine , #research & #experimental
92/285 (Q2) in Biochemistry & Molecular Biology

[jemma ai @jemma_ai]

Good news! 🥳🥳🥳

[Biomedicines MDPI @Biomed_MDPI]

👉Good news ! Biomedicines 2022's #CiteScore by #Scopus is out. Increased from 3.0 to 3.7 !

🏅Biomedicines rank #132 out of 309 in the field of #Medicine.

🙌🙌Thanks to our editor-in-chief, editorial board members, authors, and reviewers.

More details:
https://t.co/ECcMNmCbyD

[Biomedicines MDPI @Biomed_MDPI]

👉Good news ! Biomedicines 2022's #CiteScore by #Scopus is out. Increased from 3.0 to 3.7 !

🏅Biomedicines rank #132 out of 309 in the field of #Medicine.

🙌🙌Thanks to our editor-in-chief, editorial board members, authors, and reviewers.

More details:
https://t.co/ECcMNmCbyD

[Biomedicines MDPI @Biomed_MDPI]

👉Delighted to share with you a special issue hosted by our editorial board member
Prof. Dr. Antonio Gomez-Muñoz
Professor of Biochemistry and Molecular Biology, Leioa, Spain

SPHINGOLIPID CLUB:
https://t.co/I6mBovpCA9

Biomedicine
https://t.co/sWnwbdIAGh

#sphingolipidclub

[jemma ai @jemma_ai]

We are pleased to announce a Special Issue entitled “Editorial Board Members' Collection Series: #infection #Diseases” to collect submissions describing the current state of the art of the field. See https://t.co/171HnCzyww… @Biomed_MDPI

[Marianna Christodoulou @m_christodoulou]

Deadline has been extended to 30 November 2023!
Looking forward to your submissions!

https://t.co/NPCQ6vIIav https://t.co/xacSZZSj97

[Biomedicines MDPI @Biomed_MDPI]

𝑩𝒊𝒐𝒎𝒆𝒅𝒊𝒄𝒊𝒏𝒆𝒔 2022 𝑩𝒆𝒔𝒕 𝑷𝒂𝒑𝒆𝒓 𝑨𝒘𝒂𝒓𝒅

🏆
Eligibility for the Award:
– Papers published in Biomedicines from 1 January 2022 to 31 December 2022
– Open to all career levels

🥇Winner: 2 reviews and 2 articles

https://t.co/jIUfcDlEq3

[Biomedicines MDPI @Biomed_MDPI]

The third live session of #ECB 2023 will start after 2 days
Live Session 3: #Biomedicine in Cardiovascular Diseases
time: 15 March 2023 at 1:30pm CET (BASEL TIME) Registration Link: https://t.co/x071AhsUqj

Welcome to Join!

[jemma ai @jemma_ai]

We are pleased to announce a Special Issue entitled “Health-Related Applications of #Natural Molecule Derived Structures” to collect submissions of original research articles or review articles. See https://t.co/vODunucdDk… @Biomed_MDPI

[jemma ai @jemma_ai]

Welcome! 🤩🤩🤩

[Biomedicines MDPI @Biomed_MDPI]

Registration for 𝐄𝐂𝐁 𝟐𝟎𝟐𝟑 𝐥𝐢𝐯𝐞 𝐬𝐞𝐬𝐬𝐢𝐨𝐧𝐬 is open now.
There will be five live sessions, all of which are completely free to attend. There is a different registration link for each live session.
Choose the one you like

https://t.co/k7eA5NgU5M

[Biomedicines MDPI @Biomed_MDPI]

Registration for 𝐄𝐂𝐁 𝟐𝟎𝟐𝟑 𝐥𝐢𝐯𝐞 𝐬𝐞𝐬𝐬𝐢𝐨𝐧𝐬 is open now.
There will be five live sessions, all of which are completely free to attend. There is a different registration link for each live session.
Choose the one you like

https://t.co/k7eA5NgU5M

[Biomedicines MDPI @Biomed_MDPI]

𝐄𝐂𝐁 𝟐𝟎𝟐𝟑 | 𝐋𝐢𝐯𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧 𝟏: #RNA 𝐏𝐫𝐨𝐜𝐞𝐬𝐬𝐢𝐧𝐠 𝐚𝐧𝐝 𝐇𝐮𝐦𝐚𝐧 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬
⌛️:2 March 2023 at 10:00am CET (BASEL TIME)
🕸️Join us: https://t.co/X1duEpe2zz

[jemma ai @jemma_ai]

We are pleased to announce a Special Issue entitled “Plant-Based Bioactive Molecules as #Anticancer #drugs /Formulations” to collect submissions of research articles or review articles describing the current state of the field. See https://t.co/B3ao2TsoyN… @Biomed_MDPI

[jemma ai @jemma_ai]

We are pleased to announce an Editorial Board Members' Collection Series: #Gene and #cell Therapy to collect submissions of original research articles or review articles. See https://t.co/OjQpC9vpyO… @Biomed_MDPI

[jemma ai @jemma_ai]

We are pleased to announce a Special Issue entitled “#Cellular and #Metabolic #Reprogramming in Cancer” to collect submissions of original research articles or review articles describing the current state of the art of the field. See https://t.co/0rc3oRDtWg… @Biomed_MDPI

[Biomedicines MDPI @Biomed_MDPI]

High Cited Researchers released by @ClarivateAG
https://t.co/dUl1UOqdAD

🤩🤩We are happy to announce 3 of our Editorial board members are featured in the list:
Dr. Guido Kroemer: Apoptosis and Autophagy
Dr. Dong-Yan Jin: Virology and Oncology
Dr. Patrick W. Serruys: Cardiology

[jemma ai @jemma_ai]

After a successful volume, we are pleased to announce a second issue "#Glomerular Microenvironment: Cellular Stress in #ChronicKidneyDisease 2.0". Read more here:
https://t.co/AusYlvzmlM
@Biomed_MDPI